50
Participants
Start Date
August 29, 2022
Primary Completion Date
October 1, 2024
Study Completion Date
March 31, 2025
Enoxaparin
"I. Platelet count 25-50,000/µL: 0.5mg/kg subcutaneously twice daily~II. Platelet count \< 25,000/µL: hold anticoagulation"
Dalteparin
"I. Platelet count 25-50,000/µL: 100 IU/kg subcutaneously daily for the first month of an acute VTE then 75 U/kg~II. Platelet count \< 25,000/µL: hold anticoagulation"
Tinzaparin
"I. Platelet count 25-50,000/µL: 87.5 units/kg subcutaneously daily~II. Platelet count \< 25,000/µL: hold anticoagulation"
NOT_YET_RECRUITING
University of Alberta, Edmonton
RECRUITING
The Ottawa Hospital, Ottawa
RECRUITING
Windsor Regional Hospital, Windsor
Lead Sponsor
Ottawa Hospital Research Institute
OTHER